M. Widel

发表

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

D. Eckland, J. Strand, M. Tan, 2005, Clinical therapeutics.

Expression of a Mutant Form of the Ferritin Light Chain Gene Induces Neurodegeneration and Iron Overload in Transgenic Mice

B. Ghetti, M. Baraibar, A. Barbeito, 2008, The Journal of Neuroscience.

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

R. Heine, L. V. Van Gaal, R. Brodows, 2005, Annals of Internal Medicine.

Long‐term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus

M. Laakso, R. Urquhart, M. Roden, 2005, Diabetic Medicine.

Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes.

D. Eckland, D. Johns, A. Ceriello, 2005, Diabetes care.

Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens

R. Urquhart, M. Roden, S. Mariz, 2005, Diabetologia.

Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes

D. Johns, M. Tan, M. Widel, 2004, Current medical research and opinion.

Clinical Laboratory Results, Old and New Pains

Mario Widel, Scott Bahlavooni, M. Widel, 2012 .

Erratum: Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes (Diabetes Care (2005) 28 (272-272))

D. Eckland, D. Johns, A. Ceriello, 2005 .